Literature DB >> 11867191

Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum.

Nancy A M van Ooteghem1, Leo W J Klomp, Gerard P van Berge-Henegouwen, Roderick H J Houwen.   

Abstract

Benign recurrent intrahepatic cholestasis (BRIC) is an autosomal recessive liver disease, characterised by intermittent attacks of cholestasis, which can start at any age and last for several weeks to months. Characteristically serum GGT activity is low and normal liver structure is preserved. Progressive familial intrahepatic cholestasis (PFIC) is another liver disease, characterised by severe cholestasis, starting almost invariably before 6 months of age. All patients progress to cirrhosis, liver failure and death, unless a liver transplantation is performed. We now identified four patients who presented in childhood with recurrent attacks of cholestasis, while in the course of the disease the cholestasis gradually became permanent. Although liver biopsies performed in the early stages of the disease showed normal liver architecture, late stage biopsies revealed evident fibrosis with porto-portal septa formation. In conclusion, the disease of these patients started with the clinical and histopathological characteristics of BRIC but progressed to PFIC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867191     DOI: 10.1016/s0168-8278(01)00299-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

1.  The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.

Authors:  Tamara Frankenberg; Tamir Miloh; Frank Y Chen; Meena Ananthanarayanan; An-Qiang Sun; Natarajan Balasubramaniyan; Irwin Arias; Kenneth D R Setchell; Frederick J Suchy; Benjamin L Shneider
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

2.  Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family.

Authors:  Yannick Beauséjour; Fernando Alvarez; Martin Beaulieu; Marc Bilodeau
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

3.  Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis.

Authors:  Teru Kumagi; E Jenny Heathcote
Journal:  Clin J Gastroenterol       Date:  2008-09-26

4.  Modified laparoscopic external biliary diversion for benign recurrent intrahepatic cholestasis in obese adolescents.

Authors:  Martin L Metzelder; Claus Petersen; Michael Melter; Benno M Ure
Journal:  Pediatr Surg Int       Date:  2006-05-05       Impact factor: 1.827

5.  Benign recurrent intrahepatic cholestasis.

Authors:  V Gupta; M Kumar; Baldev D Bhatia
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

6.  Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.

Authors:  Giovanni Vitale; Stefano Gitto; Francesco Raimondi; Alessandro Mattiaccio; Vilma Mantovani; Ranka Vukotic; Antonietta D'Errico; Marco Seri; Robert B Russell; Pietro Andreone
Journal:  J Gastroenterol       Date:  2017-12-13       Impact factor: 7.527

Review 7.  Genetics of familial intrahepatic cholestasis syndromes.

Authors:  S W C van Mil; R H J Houwen; L W J Klomp
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

8.  New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.

Authors:  Hamoud Alhebbi; Abdul Ali Peer-Zada; Abdulrahman A Al-Hussaini; Sara Algubaisi; Awad Albassami; Nasser AlMasri; Yasir Alrusayni; Ibrahim M Alruzug; Essa Alharby; Manar A Samman; Syed Zubair Ayoub; Sateesh Maddirevula; Roy W A Peake; Fowzan S Alkuraya; Sami Wali; Naif A M Almontashiri
Journal:  J Hum Genet       Date:  2020-08-06       Impact factor: 3.172

9.  Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1.

Authors:  Frank Chen; Ayantika Ghosh; Benjamin L Shneider
Journal:  J Lipid Res       Date:  2012-12-04       Impact factor: 5.922

10.  Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.

Authors:  Bao-Cheng Deng; Sa Lv; Wei Cui; Rui Zhao; Xu Lu; Jian Wu; Pei Liu
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.